Position in SNY
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$702,524
-$116,198 QoQ
Shares Held
16,468
-3.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#283
of 712 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Investors Research Corp holds $5,482,615 across 10 Drug Manufacturers - General names. SNY ranks #5 (12.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
8,779 | $1,128,101 | |
| 2 | PFE |
Pfizer Inc
|
38,962 | $938,204 | |
| 3 | NVO |
Novo Nordisk A S
|
18,225 | $873,706 | |
| 4 | GSK |
GSK plc
|
14,952 | $783,783 | |
| 5 | SNY |
Sanofi
This page
|
16,468 | $702,524 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
8,628 | $497,145 | |
| 7 | BIIB |
Biogen Inc.
|
1,641 | $354,554 | |
| 8 | AZN |
Astrazeneca PLC
|
642 | $121,736 |
All Filings in SNY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $702,524 | 16,468 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $818,722 | 16,993 | Shares | Sole | 2026-04-03 | |
| 2025-12-31 | $12,987 | 268 | Shares | Sole | 2026-01-06 | |
| 2025-09-30 | $12,649 | 268 | Shares | Sole | 2025-10-02 | |
| 2025-06-30 | $12,947 | 268 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $14,863 | 268 | Shares | Sole | 2025-04-08 | |
| 2024-06-30 | $575,835 | 11,868 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $576,784 | 11,868 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $632,466 | 12,718 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $682,193 | 12,718 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $731,315 | 13,568 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,492,958 | 27,434 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,340,736 | 27,684 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $1,052,735 | 27,689 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,384,079 | 27,665 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $1,433,156 | 27,915 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $1,398,541 | 27,915 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $1,345,782 | 27,915 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $1,470,003 | 27,915 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $1,380,675 | 27,915 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $1,374,611 | 28,290 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $1,425,580 | 28,415 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $1,476,110 | 28,915 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $1,275,093 | 29,165 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||